Association of Diabetes With Atrial Fibrillation Phenotype and Cardiac and Neurological Comorbidities

Authors: Arjola Bano, MD, PhD; Nicolas Rodondi, MD, MAS; Jürg H. Beer, MD; Giorgio Moschovitis, MD; Richard Kobza, MD; Stefanie Aeschbacher, PhD; Oliver Baretella, MD, PhD; Taulant Muka, MD, PhD; Christoph Stettler, MD; Oscar H. Franco, MD, PhD; Giulio Conte, MD, PhD; Christian Sticherling, MD; Christine S. Zuern, MD; David Conen, MD, MPH; Michael Kühne, MD; Stefan Osswald, MD; Laurent Roten, MD; Tobias Reichlin, MD.

Summary

Multicenter analysis of Swiss-AF cohort that compared AF phenotype (type, symptoms), quality of life, and cardiac/neurologic comorbidities between patients with vs. without diabetes.

Talking Points and Key Takeaways

Patients who have AF with diabetes less often perceive AF symptoms but have worse quality of life and more cardiac and neurological comorbidities than those without diabetes - supporting vigilance for silent AF and consideration of proactive screening in diabetes.

The content on iRhythm Academy is provided for general educational purposes only and should not be considered the exclusive source for this type of information. This training does not replace or supersede approved labeling. The content will be shared with physicians and healthcare professionals who seek a deeper understanding of the operation and use of iRhythm products and services with the intent of enhancing their knowledge of features and operations described in the clinician manuals. At all times, it is the professional responsibility of the physicians and healthcare professionals to exercise independent clinical judgment in a particular situation. The device and service functionality and programming described on iRhythm Academy are based on its products and services, and can be referenced in the labeling and reference manuals. This website is intended for healthcare professionals and not intended for patients or consumers.